The comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitis

Basit Öğe Kaydı
dc.contributor.authorAksahin, Ertugrul
dc.contributor.authorDogruyol, Daghan
dc.contributor.authorYuksel, Halil Yalcm
dc.contributor.authorHapa, Onur
dc.contributor.authorDogan, Ozgur
dc.contributor.authorCelebi, Levent
dc.contributor.authorBicimoglu, Ali
dc.date.accessioned2024-09-18T20:54:17Z
dc.date.available2024-09-18T20:54:17Z
dc.date.issued2012
dc.departmentHatay Mustafa Kemal Üniversitesien_US
dc.description.abstractIn this study, the results of local injection of platelet-rich plasma (PRP) and corticosteroids in the treatment of plantar fasciitis were compared. Sixty patients who were diagnosed as plantar fasciitis and treated conservatively for at least 3 months and had no response to conservative treatment modalities were involved in this study. The first 30 consecutive patients were treated by local injection of 2 mL of 40 mg Methylprednisolone with 2 mL of 2% prilocaine (metilprednizalone) and the second 30 patients were treated by injecting 3 mL PRP after 2 mL of 2% prilocaine injection. Patients were evaluated according to the modified criteria of the Roles and Maudsley scores and visual analog scale before injection and 3 weeks and 6 months following injection. The mean VAS heel pain scores measured 6 months after treatment were 3.4 in steroid group and 3.93 in PRP group, and the scores in both groups were significantly lower when compared with pretreatment levels (6.2 in steroid group and 7.33 in PRP group). There was no significant difference between steroid and PRP groups in visual analog scale scores and modified criteria of the Roles and Maudsley scores measured at 3 weeks and 6 months ( > 0.05). Our results revealed that both methods were effective and successful in treating plantar fasciitis. When the potential complication of corticosteroid treatment was taken into consideration, PRP injection seems to be safer and at least having same effectivity in the treatment of plantar fasciitis.en_US
dc.identifier.doi10.1007/s00402-012-1488-5
dc.identifier.endpage785en_US
dc.identifier.issn0936-8051
dc.identifier.issue6en_US
dc.identifier.pmid22399039en_US
dc.identifier.scopus2-s2.0-84864947670en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage781en_US
dc.identifier.urihttps://doi.org/10.1007/s00402-012-1488-5
dc.identifier.urihttps://hdl.handle.net/20.500.12483/11723
dc.identifier.volume132en_US
dc.identifier.wosWOS:000304209500006en_US
dc.identifier.wosqualityQ3en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofArchives of Orthopaedic and Trauma Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectPlantar fasciitisen_US
dc.subjectPlatelet-rich plasmaen_US
dc.subjectCorticosteroiden_US
dc.titleThe comparison of the effect of corticosteroids and platelet-rich plasma (PRP) for the treatment of plantar fasciitisen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
[ N/A ]
İsim:
Tam Metin / Full Text
Boyut:
265.1 KB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu